Literature DB >> 29541926

P2X7 receptor and klotho expressions in diabetic nephropathy progression.

A M Rodrigues1,2, R S Serralha2,3, C Farias2,3, G R Punaro2,3, M J S Fernandes4, Elisa Mieko Suemitsu Higa5,6,7,8.   

Abstract

Diabetes mellitus is characterized by increased levels of reactive oxygen species (ROS), leading to high levels of adenosine triphosphate (ATP) and the activation of purinergic receptors (P2X7), which results in cell death. Klotho was recently described as a modulator of oxidative stress and as having anti-apoptotic properties, among others. However, the roles of P2X7 and klotho in the progression of diabetic nephropathy are still unclear. In this context, the aim of the present study was to characterize P2X7 and klotho in several stages of diabetes in rats. Diabetes was induced in Wistar rats by streptozotocin, while the control group rats received the drug vehicle. From the 1st to 8th weeks after the diabetes induction, the animals were placed in metabolic cages on the 1st day of each week for 24 h to analyze metabolic parameters and for the urine collection. Then, blood samples and the kidneys were collected for biochemical analysis, including Western blotting and qPCR for P2X7 and klotho. Diabetic rats presented a progressive loss of renal function, with reduced nitric oxide and increased lipid peroxidation. The P2X7 and klotho expressions were similar up to the 4th week; then, P2X7 expression increased in diabetes mellitus (DM), but klotho expression presented an opposite behavior, until the 8th week. Our data show an inverse correlation between P2X7 and klotho expressions through the development of DM, which suggests that the management of these molecules could be useful for controlling the progression of this disease and diabetic nephropathy.

Entities:  

Keywords:  Diabetes mellitus; Kidneys; Klotho; Oxidative stress; Purinergic receptor

Mesh:

Substances:

Year:  2018        PMID: 29541926      PMCID: PMC5940629          DOI: 10.1007/s11302-018-9602-y

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  42 in total

Review 1.  Klotho: a novel regulator of calcium and phosphorus homeostasis.

Authors:  Chou-Long Huang; Orson W Moe
Journal:  Pflugers Arch       Date:  2011-03-29       Impact factor: 3.657

2.  ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.

Authors:  Kehong Chen; Jianguo Zhang; Weiwei Zhang; Jinhua Zhang; Jurong Yang; Kailong Li; Yani He
Journal:  Int J Biochem Cell Biol       Date:  2013-02-19       Impact factor: 5.085

Review 3.  Klotho and kidney disease.

Authors:  Ming-Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  J Nephrol       Date:  2010 Nov-Dec       Impact factor: 3.902

Review 4.  The effects of dietary restriction on oxidative stress in rodents.

Authors:  Michael E Walsh; Yun Shi; Holly Van Remmen
Journal:  Free Radic Biol Med       Date:  2013-06-04       Impact factor: 7.376

Review 5.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 6.  Klotho.

Authors:  Makoto Kuro-o
Journal:  Pflugers Arch       Date:  2010-01       Impact factor: 3.657

Review 7.  Alpha Klotho and phosphate homeostasis.

Authors:  A Bian; C Xing; M C Hu
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

8.  Hyperglycemia alters E-NTPDases, ecto-5'-nucleotidase, and ectosolic and cytosolic adenosine deaminase activities and expression from encephala of adult zebrafish (Danio rerio).

Authors:  Katiucia Marques Capiotti; Anna Maria Siebel; Luiza Wilges Kist; Maurício Reis Bogo; Carla Denise Bonan; Rosane Souza Da Silva
Journal:  Purinergic Signal       Date:  2016-01-14       Impact factor: 3.765

9.  Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.

Authors:  Andrea Vergani; Carmen Fotino; Francesca D'Addio; Sara Tezza; Michele Podetta; Francesca Gatti; Melissa Chin; Roberto Bassi; Ruth D Molano; Domenico Corradi; Rita Gatti; Maria E Ferrero; Antonio Secchi; Fabio Grassi; Camillo Ricordi; Mohamed H Sayegh; Paola Maffi; Antonello Pileggi; Paolo Fiorina
Journal:  Diabetes       Date:  2013-01-11       Impact factor: 9.461

10.  Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.

Authors:  Catalina Kretschmar; Carlos Oyarzún; Cristopher Villablanca; Catherinne Jaramillo; Sebastián Alarcón; Gustavo Perez; Montserrat M Díaz-Encarnación; Marçal Pastor-Anglada; Wallys Garrido; Claudia Quezada; Rody San Martín
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more
  5 in total

1.  P2X7 receptors and klotho.

Authors:  Robert Unwin
Journal:  Purinergic Signal       Date:  2020-06       Impact factor: 3.765

Review 2.  Extracellular Nucleotides and P2 Receptors in Renal Function.

Authors:  Volker Vallon; Robert Unwin; Edward W Inscho; Jens Leipziger; Bellamkonda K Kishore
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

Review 3.  Klotho: A Possible Role in the Pathophysiology of Nephrotic Syndrome.

Authors:  Sojit Tomo; Amandeep Birdi; Dharmveer Yadav; Manish Chaturvedi; Praveen Sharma
Journal:  EJIFCC       Date:  2022-04-11

4.  P2X7 receptor-nitric oxide interaction mediates apoptosis in mouse immortalized mesangial cells exposed to high glucose.

Authors:  Thamires de Oliveira Fernandes; Adelson Marçal Rodrigues; Giovana Rita Punaro; Deyse Yorgos de Lima; Elisa Mieko Suemitsu Higa
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

5.  P2X7 siRNA targeted to the kidneys increases klotho and delays the progression of experimental diabetic nephropathy.

Authors:  A M Rodrigues; R S Serralha; D Y Lima; G R Punaro; I Visona; M J S Fernandes; E M S Higa
Journal:  Purinergic Signal       Date:  2020-05-06       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.